Recurrent coronary disease in HIV-infected patients: role of drug–drug interactions

Iria Bravo; Hortensia Álvarez; Ana Mariño; Bonaventura Clotet; José Moltó

doi:10.1111/bcp.13583

Recurrent coronary disease in HIV-infected patients: role of drug–drug interactions

Iria Bravo, Hortensia Álvarez, Ana Mariño, Bonaventura Clotet, José Moltó

Department of Medicine

Research output: Contribution to journal › Article › Research › peer-review

5 Citations (Scopus)

Abstract

© 2018 The British Pharmacological Society Cardiovascular disease represents a leading comorbidity in HIV populations. Different factors may contribute to the recurrence of cardiovascular events in HIV-infected patients. Here, we describe two patients with HIV infection and an acute coronary syndrome who developed in-stent thrombosis after a percutaneous revascularization procedure. Also, we discuss the potential role of drug interactions between antiretroviral and antiplatelet treatments as a contributing factor for recurrent coronary disease in HIV-infected patients.

Original language	English
Pages (from-to)	1617-1619
Journal	British Journal of Clinical Pharmacology
Volume	84
Issue number	7
DOIs	https://doi.org/10.1111/bcp.13583
Publication status	Published - 1 Jul 2018

Keywords

HIV infection
coronary disease
drug interactions

Access to Document

10.1111/bcp.13583

Fingerprint Dive into the research topics of 'Recurrent coronary disease in HIV-infected patients: role of drug–drug interactions'. Together they form a unique fingerprint.

Cite this

@article{ea55b47ebefe404ab71f9a6ea5393b0b,

title = "Recurrent coronary disease in HIV-infected patients: role of drug–drug interactions",

abstract = "{\textcopyright} 2018 The British Pharmacological Society Cardiovascular disease represents a leading comorbidity in HIV populations. Different factors may contribute to the recurrence of cardiovascular events in HIV-infected patients. Here, we describe two patients with HIV infection and an acute coronary syndrome who developed in-stent thrombosis after a percutaneous revascularization procedure. Also, we discuss the potential role of drug interactions between antiretroviral and antiplatelet treatments as a contributing factor for recurrent coronary disease in HIV-infected patients.",

keywords = "HIV infection, coronary disease, drug interactions",

author = "Iria Bravo and Hortensia {\'A}lvarez and Ana Mari{\~n}o and Bonaventura Clotet and Jos{\'e} Molt{\'o}",

year = "2018",

month = jul,

day = "1",

doi = "10.1111/bcp.13583",

language = "English",

volume = "84",

pages = "1617--1619",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

number = "7",

}

TY - JOUR

T1 - Recurrent coronary disease in HIV-infected patients: role of drug–drug interactions

AU - Bravo, Iria

AU - Álvarez, Hortensia

AU - Mariño, Ana

AU - Clotet, Bonaventura

AU - Moltó, José

PY - 2018/7/1

Y1 - 2018/7/1

N2 - © 2018 The British Pharmacological Society Cardiovascular disease represents a leading comorbidity in HIV populations. Different factors may contribute to the recurrence of cardiovascular events in HIV-infected patients. Here, we describe two patients with HIV infection and an acute coronary syndrome who developed in-stent thrombosis after a percutaneous revascularization procedure. Also, we discuss the potential role of drug interactions between antiretroviral and antiplatelet treatments as a contributing factor for recurrent coronary disease in HIV-infected patients.

AB - © 2018 The British Pharmacological Society Cardiovascular disease represents a leading comorbidity in HIV populations. Different factors may contribute to the recurrence of cardiovascular events in HIV-infected patients. Here, we describe two patients with HIV infection and an acute coronary syndrome who developed in-stent thrombosis after a percutaneous revascularization procedure. Also, we discuss the potential role of drug interactions between antiretroviral and antiplatelet treatments as a contributing factor for recurrent coronary disease in HIV-infected patients.

KW - HIV infection

KW - coronary disease

KW - drug interactions

U2 - 10.1111/bcp.13583

DO - 10.1111/bcp.13583

M3 - Article

VL - 84

SP - 1617

EP - 1619

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 7

ER -